Marika Sherman
About Marika Sherman
Marika Sherman is an Associate Director at Kite Pharma, where she has worked since 2021. She has a background in cancer research and extensive experience in proteomic biomarker discovery, having held various roles in prominent biotech companies.
Work at Kite Pharma
Marika Sherman has held multiple positions at Kite Pharma, Inc. She began her tenure as a Principal Research Associate from 2015 to 2017, contributing to various projects in cancer research. Following this role, she advanced to the position of Scientist from 2017 to 2021, where she continued her work in Santa Monica, CA. In 2021, she was promoted to Associate Director, a role she currently occupies. In this capacity, she applies innovative ideas to drive projects forward, demonstrating her commitment to advancing the field of cancer research.
Education and Expertise
Marika Sherman earned her Bachelor of Science (BS) in Chemistry from Rutgers, The State University of New Jersey-New Brunswick, completing her studies from 2000 to 2004. She furthered her education by obtaining a Master of Science in Health Sciences (MSHS) in Clinical Research Administration from The George Washington University School of Medicine and Health Sciences, which she completed from 2007 to 2009. Her academic background supports her extensive experience in proteomic biomarker discovery and personalized healthcare.
Background
Marika Sherman's professional journey includes various roles in the biotechnology and pharmaceutical industries. She began her career as a Research Associate at Calypte Biomedical from 2004 to 2005. Following this, she worked at BioAssay Works, LLC, and MedImmune, where she served as Associate Scientist 1 from 2006 to 2013. She then transitioned to Amgen as an Associate Scientist from 2013 to 2015 before joining Kite Pharma. Her diverse experience has equipped her with strong critical thinking and organizational skills.
Achievements
Throughout her career, Marika Sherman has been recognized for her contributions to cancer research and personalized healthcare. She is known for applying innovative ideas and approaches to drive projects forward. Her extensive experience in proteomic biomarker discovery has significantly impacted the field, showcasing her ability to balance multiple projects effectively and meet deadlines.